NVS
Novartis AG
DRUG MANUFACTURERS - GENERAL · HEALTHCARE
Novartis AG (ADR), based in Basel, Switzerland, is a premier global healthcare leader specializing in the research, development, manufacturing, and commercialization of innovative pharmaceuticals and medical devices. The company boasts a comprehensive portfolio of patented therapies across crucial t...
$150.49
+0.03% (+$0.05)
Volume
1.35M
52W High
$170.46
52W Low
$111.06
Market Cap
$275.14B
What to Watch This Quarter
Based on historical dataConsensus EPS
$2.11
Whisper EPS
$2.09
0.7% below consensus
Last Quarter
$1.99
Current Streak
1 Miss
Avg Surprise (4Q)
-1.93%
Next Earnings Report
Reports in 60 days
Price Chart
EPS History: Consensus vs Actual
Last 12 quartersPrice Movement Around Earnings
Q1 2026
Apr 28, 2026
1-Day:
-1.76%
Q1 2026
Apr 27, 2026
1-Day:
+0.91%
Q4 2025
Feb 4, 2026
1-Day:
+0.68%
5-Day:
+2.71%
Q3 2025
Oct 28, 2025
1-Day:
-1.32%
Revenue & Financial Performance
Revenue Whisper
$14.21B
TWN Proprietary Estimate
Last Quarter Revenue
$13.52B
-0.7% YoY
Gross Margin
74.4%
Net Margin: 23.3%
| Quarter | Revenue | YoY Growth | Gross Margin | Op Margin | Net Income |
|---|---|---|---|---|---|
| Q1'26 | $13.52B | -0.7% | 74.4% | 31.3% | $3.16B |
| Q4'25 | $13.33B | -1.6% | 73.4% | 26.4% | $2.41B |
| Q3'25 | $14.36B | +9.0% | 75.4% | 31.4% | $3.93B |
| Q2'25 | $14.84B | +15.3% | 77.6% | 32.8% | $4.04B |
| Q1'25 | $13.62B | +12.4% | 76.3% | 34.2% | $3.61B |
| Q4'24 | $13.56B | +15.1% | 75.5% | 26.0% | $2.82B |
| Q3'24 | $13.17B | +8.9% | 75.5% | 27.5% | $3.19B |
| Q2'24 | $12.87B | +9.6% | 75.4% | 31.2% | $3.25B |
Company Information
Symbol
NVS
Company
Novartis AG
Market Cap
$275.14B
Sector
HEALTHCARE
Next Earnings
Jul 21, 2026
Also Reporting Soon
Companies reporting earnings around the same time as NVS
HEALTHCARE Stocks
Other healthcare companies with earnings data
More in DRUG MANUFACTURERS - GENERAL
Compare NVS with competitors
Side-by-side earnings comparison